London, UK, 9 June 2008 Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce the publication of Bioscience Hypotheses (http://www.sciencedirect.com/science/journal/17562392), a new journal for radical hypotheses on topics throughout the life sciences.
The aim of the journal is to stimulate innovation by choosing work that is interesting and challenging, and provides a clear and coherent argument with a testable conclusion. Bioscience Hypotheses is edited by Dr William Bains, biotechnology entrepreneur and innovator, and visiting lecturer at the University of Cambridge.
The journal welcomes papers that:
Papers that do not provide a means of testing their conclusion, or differentiating their conclusion from other explanations, will be rejected. Papers that provide some preliminary data (itself perhaps not sufficiently robust to be published as an independent paper, but nevertheless rigorously collected) will be welcomed. However, preliminary data are not a requirement for publication, and Bioscience Hypotheses is not a forum for new experimental results unless they are supporting a broader theoretical structure.
Papers are not subject to standard peer review, but are selected by the Editor on the basis of the criteria laid out above. The journal explicitly does not publish papers addressing medical issues, which should continue to be directed to the sister journal Med
|Contact: Samantha Savalio|